MENLO PARK, Calif., June 25, 2026 /PRNewswire/ — GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced the closing of its previously announced equity financing with Samsung affiliates including Samsung C&T…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
